BioCentury
ARTICLE | Politics & Policy

CMS to overhaul Part B drug purchasing

July 26, 2018 9:20 PM UTC

CMS is moving forward with plans to overhaul the way Medicare purchases infused and injected drugs that are administered under a physician’s supervision. It has requested public comment on proposals for implementing a Competitive Acquisition Program (CAP) in which private plans, similar to those that negotiate drug prices in Medicare Part D, would negotiate prices for drugs purchased by Medicare Part B.

CMS said CAP could increase competition in Medicare Part B drug payment negotiations, incentivize lower list prices and facilitate value-based drug payments...